# Oramed Pharmaceuticals Inc.: Form 8-K, filed Oct 6, 2025

- Company: [Oramed Pharmaceuticals Inc.](/companies/ormp.md) (CIK 1176309)
- Form: 8-K
- Filed: 2025-10-06
- Accepted by EDGAR: Oct 6, 2025, 13:28 ET
- Period: 2025-09-30
- Accession: 0001213900-25-096322
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1176309/000121390025096322/ea0260371-8k_oramed.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1176309/000121390025096322/

## Items reported

- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1176309/000121390025096322/ea0260371-8k_oramed.htm

Filed Oct 6, 2025.
Source: SEC EDGAR, the filing index for accession 0001213900-25-096322. Last ingested by Listed: Oct 24, 2026, 15:06 ET. No prices; not investment advice.